ROVATINEKS

Active material: anethole, ʙorneol, camphene, a,b-пинен, fenchone, Cineol
When ATH: G04BX
CCF: Phytopreparation a diuretic, antispasmodic action and litholytic
ICD-10 codes (testimony): N20, N21
At KFU: 28.03.03
Manufacturer: Rowan PHARMACEUTIKALS Ltd. (Ireland)

Pharmaceutical form, composition and packaging

Enteric capsules spherical gelatin, yellow color; contents of capsules – Liquid pale yellow or greenish-yellow, with a strong aromatic odor.

Excipients: olive oil.

The composition of the shell: gelatin, glycerol 85%, sodium ethyl parahydroxybenzoate, sodium propyl parahydroxybenzoate, quinoline zheltыy WS 70% (E104), Sunset Yellow FCF 85% (E110).

10 PC. – blisters (5) – packs cardboard.
10 PC. – blisters (10) – packs cardboard.

Pharmacological action

Phyto, promoting disintegration and removal of kidney stones and urinary tract stones.

Terpenı, such as borneol, undergo metabolic changes, and excreted in the urine, primarily, in the form of glucuronides, that increases the solubility of calcium salts, which are the main components of kidney stones and urinary tract stones.

In experimental studies, it was set Rovatineksa inhibitory effect on the formation of kidney stones and urinary tract stones.

Rovatineks has antispasmodic action, It facilitates the passage of urinary tract stones, It reduces pain in the kidney and ureteral colic, increases renal blood flow, improving renal function and increasing urine output.

The drug has anti-inflammatory action, Antimicrobial (in relation to a range of Gram microorganisms and grampolozhiteliyh), increases the content of protective colloid in the urine and increase the content of glucuronic acid in the urine.

Pharmacokinetics

The participants in the preparation of terpenes fat soluble and easily absorbed.

Terpenı, such as borneol, largely undergo metabolic changes in the human body, turning into a glucuronide, are excreted in the urine.

Testimony

- Urolithiasis disease (nephrolithiasis, urolithiasis);

- Prevention of kidney stones and urinary tract.

Dosage regimen

The drug is taken orally before a meal.

Adults and children over 14 years appoint 1-2 caps. 3 times / day. At renal colic the dose can be increased to 2-3 caps. 4-5 time / day.

For children 6-14 years the drug is prescribed for 1 caps. 2 times / day.

Side effect

From the digestive system: rarely – mild and transient stomach discomfort; rarely – vomiting.

Other: in 2 patients was seen drug intolerance (cause unknown).

Contraindications

- Children up to age 6 years;

- Hypersensitivity to the drug.

FROM caution should be prescribed at the same time taking oral anticoagulants and drugs, predominantly metabolized in the liver.

Pregnancy and lactation

We do not recommend the use of Rovatineksa I trimester of pregnancy and lactation.

Cautions

Not recommended Rovatineks with severe renal colic, anuria or severe infections of the urinary tract.

During treatment you should increase your fluid intake.

Overdose

Treatment: gastric lavage (if the drug has recently adopted); should establish monitoring of patients (cardiac monitoring, respiratory, kidney and liver functions); if necessary, symptomatic therapy.

Drug Interactions

In an application Rovatineks can alter the activity of anticoagulants, as well as preparations, metabolized in the liver.

Conditions of supply of pharmacies

The drug is released under the prescription.

Conditions and terms

The drug should be stored out of reach of children at or above 25 ° C. Shelf life – 5 years.